Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer

Abstract

Endometrial cancers constitute more than half of all gynecologic cancer diagnoses in the United States. 1 Pathologic evaluation is an important element of disease management. As management approaches continue to evolve in response to reported data from clinicopathologic and molecular genetic studies, pathology will continue to play a central role in diagnosis, prognostic assessment, and treatment planning.